Clinical Trials

Showing trials with last updates posted in 2024.

NCT03588104 | COMPLETED | NA
222 participants

"POWER2DM Evaluation Campaign"

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-13
Start Date:
2018-12-03
Completion:
2020-10-31
Conditions
  • Type1 Diabetes Mellitus
  • Type2 Diabetes Mellitus
  • Diabetes Mellitus
  • Health Behavior
  • Self Efficacy
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT02923739 | TERMINATED | PHASE2
9 participants

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-13
Start Date:
2017-05-05
Completion:
2022-09-27
Conditions
  • Fallopian Tube Adenocarcinoma
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Mucinous Adenocarcinoma
  • Fallopian Tube Serous Adenocarcinoma
  • Fallopian Tube Transitional Cell Carcinoma
  • Fallopian Tube Undifferentiated Carcinoma
  • Malignant Ovarian Brenner Tumor
  • Ovarian Adenocarcinoma
  • Ovarian Clear Cell Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Ovarian Serous Adenocarcinoma
  • Ovarian Transitional Cell Carcinoma
  • Ovarian Undifferentiated Carcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page